Drug Discovery Preclinical Phase 1 Phase 2 Phase 3
120,000 Compounds Library
Partners

Cooperation with NCI
Ozarelix:
Spectrum Pharmaceuticals
world (ex-Japan, Korea and ex-other Asian countries)

Nippon Kayaku
Japan for oncology indications

Handok Pharmaceuticals
Korea and other Asian countries for BPH indication

Perifosine:
Yakult Honsha
Japan

Handok Pharmaceuticals
Korea

Hikma Pharmaceuticals
Middle East/North Africa

Oncology Oncology Endocrine Therapy Endocrine Therapy